Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Cancer Research|October 1, 2020
Specific Mechanisms of Chromosomal Instability Indicate Therapeutic Sensitivities in High-Grade Serous Ovarian CarcinomaNaoka Tamura, Nadeem Shaikh, Daniel Muliaditan, et al.
The Journal of Pathology|February 11, 2012
The peritoneal tumour microenvironment of high-grade serous ovarian cancerD Andrew Leinster, Hagen Kulbe, Gemma Everitt, et al.
Nature Communications|March 26, 2026
3D pentaculture model unveils malignant cell-driven macrophage polarization in high-grade serous ovarian cancerBeatrice Malacrida, Samar Elorbany, Florian Laforêts, et al.
Iscience|June 30, 2021
A human multi-cellular model shows how platelets drive production of diseased extracellular matrix and tissue invasionBeatrice Malacrida, Sam Nichols, Eleni Maniati, et al.
Cancer Immunology, Immunotherapy : CII|July 28, 2007
Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cellsSophia N Karagiannis, Marguerite G Bracher, Rebecca L Beavil, et al.
Oncotarget|February 13, 2016
Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cellsHagen Kulbe, Francesco Iorio, Probir Chakravarty, et al.
Molecular Cancer Therapeutics|April 28, 2025
Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor GrowthHilary A Kenny, Carman Ka Man Ip, Lucy Kelliher, et al.
Iscience|April 17, 2026
Matrix structure and microenvironment dynamics correlate with chemotherapy response in ovarian cancerFlorian Laforêts, Panoraia Kotantaki, Samar Elorbany, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2016
A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian MetastasesAnne Montfort, Oliver Pearce, Eleni Maniati, et al.
Cancer Research|August 18, 2016
CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous CarcinomaJosephine Walton, Julianna Blagih, Darren Ennis, et al.
Pageof 8